Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02455479 · ClinicalTrials.gov registry record · Phase 1

Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals

A Phase 1 study of Cocaine Dependence, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
Phase 1
Development phase
150
Enrollment target
1
Study location

NCT02455479 is a Phase 1 study of Cocaine Dependence that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 150 participants, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02455479, a Phase 1 study of Cocaine Dependence, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
Phase 1
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the safety and preliminary efficacy of an anti-cocaine vaccine called dAd5GNE in cocaine-dependent individuals. It uses the concept of a vaccine to treat the neurological effects of cocaine by evoking "immunity" to prevent the effects of cocaine on the brain.

Conditions Studied

Cocaine Dependence

Interventions

  • BIOLOGICAL Placebo
  • BIOLOGICAL dAd5GNE Vaccine

Study Locations (1)

New York

  • WCMC Department of Genetic Medicine - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2012-06-26
Est. Completion 2027-12
Phase Phase 1

Sponsor

Weill Medical College of Cornell University

701 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02455479

The ClinicalTrials.gov registry entry for NCT02455479 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (49% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02455479 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02455479 about?

NCT02455479 is a clinical study titled "Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals". The purpose of this study is to assess the safety and preliminary efficacy of an anti-cocaine vaccine called dAd5GNE in cocaine-dependent individuals. It uses the concept of a vaccine to treat the neurological effects of cocaine by evoking "immunity" to prevent the effects of cocaine on the brain.

What is the current status of trial NCT02455479?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2012-06-26. Estimated completion is 2027-12.

What conditions does trial NCT02455479 study?

This clinical trial studies the following conditions: Cocaine Dependence.

What interventions are being tested in trial NCT02455479?

The interventions under investigation include: Placebo (BIOLOGICAL), dAd5GNE Vaccine (BIOLOGICAL).

Who is sponsoring clinical trial NCT02455479?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02455479 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cocaine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cocaine Dependence

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.